Uterotonics for post-partum haemorrhage

Document Type

Journal Article

Publication Title

Nurse Prescribing

Publisher

EMAP Healthcare

School

School of Nursing and Midwifery

RAS ID

23488

Comments

Wright, C., & Geraghty, S. (2017). Uterotonics for post-partum haemorrhage. Nurse Prescribing, 15(1), 23-26. https://doi.org/10.12968/npre.2017.15.1.23

Abstract

The active management of the third stage of labour has been defined as the interval between the birth of the neonate and expulsion of the placenta, with the use of an oxytocic drug administered immediately after birth, early cord clamping and cutting, and controlled cord traction (Deneux-Tharaux et al, 2013). Synthetic uterotonics are designed to stimulate contraction of the uterus, in order to prevent post-partum haemorrhage (PPH), as uterine atony accounts for 90% of primary PPH in woman globally (Say et al, 2014). Oxytocin, Syntometrine, ergometrine, and misoprostol, remain the front line drug therapies used to prevent and manage this complication.

DOI

10.12968/npre.2017.15.1.23

Access Rights

subscription content

Link to Full Text

Share

 
COinS